These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16420762)

  • 1. [A clinical study of abnormal bone metabolism in patients with HBV liver cirrhosis].
    Wang YG; Liu Q; Wang WQ; Chen ZP; Yan MX
    Zhonghua Gan Zang Bing Za Zhi; 2006 Jan; 14(1):33-6. PubMed ID: 16420762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis.
    Gallego-Rojo FJ; Gonzalez-Calvin JL; Muñoz-Torres M; Mundi JL; Fernandez-Perez R; Rodrigo-Moreno D
    Hepatology; 1998 Sep; 28(3):695-9. PubMed ID: 9731561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alendronate reduces serum TNFalpha and IL-1beta, increases neutrophil counts, and improves bone mineral density and bone metabolism indices in patients with chronic idiopathic neutropenia (CIN)-associated osteopenia/osteoporosis.
    Papadaki HA; Tsatsanis C; Christoforidou A; Malliaraki N; Psyllaki M; Pontikoglou C; Miliaki M; Margioris AN; Eliopoulos GD
    J Bone Miner Metab; 2004; 22(6):577-87. PubMed ID: 15490268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The "lively" cytokines network in beta-Thalassemia Major-related osteoporosis.
    Morabito N; Russo GT; Gaudio A; Lasco A; Catalano A; Morini E; Franchina F; Maisano D; La Rosa M; Plota M; Crifò A; Meo A; Frisina N
    Bone; 2007 Jun; 40(6):1588-94. PubMed ID: 17412659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and ascites levels of macrophage migration inhibitory factor, TNF-alpha and IL-6 in patients with chronic virus hepatitis B and hepatitis cirrhosis.
    Zhang W; Yue B; Wang GQ; Lu SL
    Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):577-80. PubMed ID: 14607690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of osteoporosis in liver cirrhosis.
    Giouleme OI; Vyzantiadis TA; Nikolaidis NL; Vasiliadis TG; Papageorgiou AA; Eugenidis NP; Harsoulis FI
    Hepatogastroenterology; 2006; 53(72):938-43. PubMed ID: 17153457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum osteoprotegerin and RANKL levels in chronic alcoholic liver disease.
    García-Valdecasas-Campelo E; González-Reimers E; Santolaria-Fernández F; De la Vega-Prieto MJ; Milena-Abril A; Sánchez-Pérez MJ; Martínez-Riera A; Gómez-Rodríguez Mde L
    Alcohol Alcohol; 2006; 41(3):261-6. PubMed ID: 16476762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
    Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
    Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between endogenous parathyroid hormone and bone metabolism/geometry in female patients treated with glucocorticoid.
    Kaji H; Yamauchi M; Chihara K; Sugimoto T
    Horm Metab Res; 2008 Jan; 40(1):60-5. PubMed ID: 18072075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low bone mineral density and impaired bone metabolism in young alcoholic patients without liver cirrhosis: a cross-sectional study.
    Malik P; Gasser RW; Kemmler G; Moncayo R; Finkenstedt G; Kurz M; Fleischhacker WW
    Alcohol Clin Exp Res; 2009 Feb; 33(2):375-81. PubMed ID: 19053976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression characteristic and significance of interleukin-6, nuclear factor kappa beta, and bone formation markers in rat models of osteoporosis.
    Zhu X; Luo J; Chen X; Wang J; Wang G; Li H; Xu Y; Feng J; Tu H
    Transl Res; 2008 Jul; 152(1):18-23. PubMed ID: 18593633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bone mineral density in patients with liver cirrhosis].
    Topcheeva ON; Drozdov VN; Embutnieks IuV; Viazhevich IuV
    Eksp Klin Gastroenterol; 2009; (8):51-5. PubMed ID: 20469679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoporosis, mineral metabolism, and serum soluble tumor necrosis factor receptor p55 in viral cirrhosis.
    Gonzalez-Calvin JL; Gallego-Rojo F; Fernandez-Perez R; Casado-Caballero F; Ruiz-Escolano E; Olivares EG
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4325-30. PubMed ID: 15356028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of bone metabolism and mineral density in chronic viral hepatitis.
    Yenice N; Gümrah M; Mehtap O; Kozan A; Türkmen S
    Turk J Gastroenterol; 2006 Dec; 17(4):260-6. PubMed ID: 17205403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum osteoprotegerin and its ligand in cirrhotic patients referred for orthotopic liver transplantation: relationship with metabolic bone disease.
    Monegal A; Navasa M; Peris P; Alvarez L; Pons F; Rodés J; Guañabens N
    Liver Int; 2007 May; 27(4):492-7. PubMed ID: 17403189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of intact parathyroid hormone level is a risk factor for low bone mineral density in pretransplant patients with liver diseases.
    Bai XL; Liang TB; Wu LH; Li DL; Geng L; Wang WL; Shen Y; Zhang M; Zheng SS
    Transplant Proc; 2007 Dec; 39(10):3182-5. PubMed ID: 18089348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between bone turnover and bone density at the proximal femur in stroke patients.
    Paker N; Bugdayci D; Tekdos D; Dere C; Kaya B
    J Stroke Cerebrovasc Dis; 2009; 18(2):139-43. PubMed ID: 19251190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone metabolism and mineral density in patients with beta-thalassemia major.
    Dundar U; Kupesiz A; Ozdem S; Gilgil E; Tuncer T; Yesilipek A; Gultekin M
    Saudi Med J; 2007 Sep; 28(9):1425-9. PubMed ID: 17768474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible association of psoriasis and reduced bone mineral density due to increased TNF-alpha and IL-6 concentrations.
    Kastelan D; Kastelan M; Massari LP; Korsic M
    Med Hypotheses; 2006; 67(6):1403-5. PubMed ID: 16844318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.